HomeWorking Group 6

Working Group 6

Preclinical Models and Development of New Therapeutic Approaches

Aim

  • Compile and develop VLD preclinical models; 
  • identify therapeutic targets; 
  • explore drug repurposing.

Deliverables

  • Publications on preclinical models and pathophysiology; 
  • Pilot preclinical therapeutic studies.

COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

COST

COST Actions - CA23146

Vascular liver diseases are a heterogeneous group of rare disorders characterized by an impaired vascular flow in the splanchnic and/or intrahepatic vasculature. They mainly include recent portal vein thrombosis, portal cavernoma, porto-sinusoidal vascular disorder, Budd-Chiari syndrome and sinusoidal obstruction syndrome.

Discover

Actions Contact

MoU – 059/24
CSO Approval Date – 17/05/2024
Start date – 30/10/2024
End date – 29/10/2028

© 2025 EURO-VALDI-NET • Cost Action CA23146 • All Right Reserved | Design by Onno Media
Join Us